Efficacy of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

NCT00763022 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

302

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: TAK-559
DRUG: TAK-559
DRUG: Placebo

Sponsor

Takeda